NCT00592930已完成4 期
Pilot Study of the Efficacy of Olanzapine in the Treatment of Anorexias Nervosa
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- weight gain
研究概览
简要总结
This study compared 10 weeks of treatment with olanzapine versus placebo in adolescent females with anorexia nervosa-restricting type who were undergoing acute treatment on an inpatient unit or a day hospital program that specializes in the treatment of eating disorders.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 12 Years 至 23 Years（Child, Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Females, ages 12-23
排除标准
- •Binge-purge type
研究组 & 干预措施
1
Experimental
olanzapine
干预措施: olanzapine (Drug)
2
Placebo Comparator
matching placebo
干预措施: placebo (Drug)
结局指标
主要结局
weight gain
时间窗: 10 weeks
次要结局
- measures of psychiatric symptoms(10 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaSchizophreniaNCT00088049Eli Lilly and Company560
已完成
3 期
Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaSchizophreniaNCT00051298Eli Lilly and Company107
已完成
2 期
A Controlled Study of Olanzapine in Children With AutismAutistic DisorderNCT00057408FDA Office of Orphan Products Development78
已完成
4 期
Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeBipolar DisorderNCT00191997Eli Lilly and Company180
已完成
2 期
Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving ChemotherapyChemotherapy Induced Nausea and VomitingNCT02097823Indiana University15